Wearables May Boost T2D Mobility - Summary - MDSpire
From the Journals

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.

  • By

  • Kathryn Wighton

  • May 11, 2026

  • 4 min

Share

A study investigating the effects of physiotherapist-guided exercise with wearable device feedback on patients with type 2 diabetes and diabetic kidney disease showed significant improvements in 6-minute walk distance over six months. Conducted with 58 outpatients, the intervention group practiced exercise regimens with data from a wrist-worn device, resulting in an increase in walk distance by 39 meters, while the control group saw a minor decline. Additional benefits included reduced glycated hemoglobin and improved muscle metrics. No adverse events were reported, but researchers note that the study's design limits definitive conclusions.

Original Source(s)

Wearables May Boost T2D Mobility

  • by Kathryn Wighton

  • May 11, 2026

Related Content

Ancient DNA Tracks 10,000 Years of Selection

Large dataset shows widespread genetic changes shaping modern traits and disease risk

  • May 12, 2026

  • 3 min
Remote Diet Support Studied in Diabetes

WhatsApp-based low-carbohydrate nutrition education was linked to short-term glycemic, weight, and medication-use improvements in a small primary care trial

Frontline Pharma: Sarah O’Keeffe

Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients